Key result
Different NFAT isoforms contribute to pulmonary vascular remodeling and represent potential new therapeutic targets for treating pulmonary arterial hypertension.
Answers are grounded in this paper and cite their sources.
This review highlights the role of NFAT isoforms in pulmonary vascular remodeling and their potential as therapeutic targets for pulmonary arterial hypertension.
Nuclear factor of activated T cells (NFAT) was first identified as a transcription factor about 3 decades ago and was not well studied until the development of immunosuppressant. Numerous studies confirm that calcineurin/NFAT signaling is very important in the development of vasculature and cardiovascular system during embryogenesis and is involved in the development of vascular diseases such as hypertension, atherosclerosis and restenosis. Recent studies demonstrated that NFAT proteins also regulate immune response and vascular cells in the pulmonary microenvironment. In this review, we will discuss how different NFAT isoforms contribute to pulmonary vascular remodeling and potential new therapeutic targets for treating pulmonary arterial hypertension.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2017) conducted a review in Pulmonary arterial hypertension. Nuclear factor of activated T cells (NFAT) was evaluated. Different NFAT isoforms contribute to pulmonary vascular remodeling and represent potential new therapeutic targets for treating pulmonary arterial hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: